window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Real World Evidence

  • Artificial Intelligence,Clinical Trials,Real world evidence,Research & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    July 17, 2025
  • Movers & Shakers

    Phastar appoints industry veteran Billy Amzal as head of strategic consulting

    Biostatistics and real-world evidence expert joins global CRO to advance [...]

    June 25, 2025
  • Artificial Intelligence,Clinical Trials

    PhaseV raises $50M to expand AI-powered clinical trial platform

    PhaseV has secured $50 million in Series A funding to [...]

    May 13, 2025
  • Clinical Trials,Patient Centricity

    Pharma giants eye obesity trial boom — but are they ready for what comes next?

    May 7, 2025
  • Movers & Shakers

    Highlander Health names Nicholaas Honig executive director, expanding institute’s vision for clinical innovation

    April 30, 2025
  • Clinical Trials

    Cefiderocol shows improved outcomes when used earlier in treatment pathway, new European data reveals

    April 24, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top